|
2025 Journal Article Antimicrobial resistance in northern Australia: the HOTspots surveillance and response program annual epidemiology report 2022Wozniak, Teresa M, Young, Alys R, Shausan, Aminath, Legg, Amy, Leung, Michael J, Coulter, Sonali A, Perera, Shalinie, Baird, Robert W and Murphy, Majella G (2025). Antimicrobial resistance in northern Australia: the HOTspots surveillance and response program annual epidemiology report 2022. Communicable Diseases Intelligence, 49, 49. doi: 10.33321/cdi.2025.49.030 |
|
2025 Journal Article Safe and effective use of vancomycinLegg, Amy, Devchand, Felicia, Gwee, Amanda, Sandaradura, Indy and Lai, Tony (2025). Safe and effective use of vancomycin. Australian Prescriber, 48 (2), 54-59. doi: 10.18773/austprescr.2025.013 |
|
2025 Journal Article Not “a cute” complication: phenotypic analysis of acute kidney injury in Staphylococcus aureus bacteraemiaLegg, Amy, Ferguson, John K., Munnoch, Sally-Anne and Davies, Joshua S. (2025). Not “a cute” complication: phenotypic analysis of acute kidney injury in Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection, 31 (4), 643-646. doi: 10.1016/j.cmi.2024.12.034 |
|
2025 Journal Article Resistance Optimised Antibiotic Dosing (The ROAD Study): Is dosing of meropenem and piperacillin-tazobactam optimised to prevent the emergence of antibiotic resistance safe and feasible in the ICU? A pilot studyRoberts, J. A., Heffernan, A. J., Chai, M. G., Harris, P. N. A., Legg, A., Farkas, A., Laupland, K., Dhanani, J., Fourie, C., Murray, L., Abdul-Aziz, H., Ungerer, J., McWhinney, B., Lipman, J. and Cotta, M. O. (2025). Resistance Optimised Antibiotic Dosing (The ROAD Study): Is dosing of meropenem and piperacillin-tazobactam optimised to prevent the emergence of antibiotic resistance safe and feasible in the ICU? A pilot study. CMI Communications, 2 (1) 105051, 105051. doi: 10.1016/j.cmicom.2024.105051 |
|
2025 Journal Article Prolonged versus single dose in penicillin oral challenge testing: protocols for a pilot and definitive randomised controlled trial (PROSPECTOR studies)Ng, Irvin, James, Fiona, Copaescu, Ana, Vogrin, Sara, Mitri, Elise, Rose, Morgan, Sullivan, Richard, Lane, Michael, Legg, Amy, Godsell, Jack, Fernando, Suran, Garvey, Lene Heise, Sabato, Vito, Li, Philip, Peter, Jonathan Grant and Trubiano, Jason (2025). Prolonged versus single dose in penicillin oral challenge testing: protocols for a pilot and definitive randomised controlled trial (PROSPECTOR studies). BMJ Open, 15 (2) e094712, e094712-2. doi: 10.1136/bmjopen-2024-094712 |
|
2024 Journal Article Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy NetworkHannah, Rory, Mitri, Elise, Katelaris, Constance H., O'Hern, Jennifer, Avent, Minyon, Valoppi, Glenn, Rawlins, Matthew, Frith, Catherine, Mcmullan, Brendan, Kong, David, Chua, Kyra, Legg, Amy, James, Rod, Janson, Sonja, Hawkins, Carolyn, Randall, Katrina, Ierano, Courtney, Thursky, Karin and Trubiano, Jason A. (2024). Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network. Internal Medicine Journal, 54 (11), 1883-1893. doi: 10.1111/imj.16543 |
|
2024 Journal Article The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsJames, Fiona, Goh, Michelle S., Vogrin, Sara, Ng, Irvin, Douglas, Abby P., Holmes, Natasha E., Chua, Kyra YL., De Luca, Joseph, Sharma, Pooja, Zubrinich, Celia, Aung, Ar K., Gin, Douglas, Lambros, Belinda, Baker, Chris, Foley, Peter, Chong, Alvin H., Thien, Francis, Fok, Jie S., Su, John, Scardamaglia, Laura, Awad, Andrew, Tong, Steven, Johnson, Douglas, Godsell, Jack, Arasu, Alexis, Barnes, Sara, Ojaimi, Samar, Mar, Adrian, Yun, James ... Trubiano, Jason A. (2024). The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions. World Allergy Organization Journal, 17 (8) 100936, 1-15. doi: 10.1016/j.waojou.2024.100936 |
|
2023 Journal Article Improving palliative and supportive care in advanced cirrhosis: the HepatoCare model of integrated collaborative careKearney, Alison, Tiwari, Neha, Cullen, Olivia, Legg, Amy, Arbi, Ismail, Douglas, Carol, Leggett, Barbara, Fenech, Mary, Mina, Joanne, Hoey, Paris and Skoien, Richard (2023). Improving palliative and supportive care in advanced cirrhosis: the HepatoCare model of integrated collaborative care. Internal Medicine Journal, 53 (11), 1963-1971. doi: 10.1111/imj.16248 |
|
2023 Journal Article Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocolde Kretser, Dana, Mora, Jocelyn, Bloomfield, Max, Campbell, Anita, Cheng, Matthew P., Guy, Stephen, Hensgens, Marjolein, Kalimuddin, Shirin, Lee, Todd C., Legg, Amy, Mahar, Robert K., Marks, Michael, Marsh, Julie, Mcglothin, Anna, Morpeth, Susan C., Sud, Archana, Ten Oever, Jaap, Yahav, Dafna, Bonten, Marc, Bowen, Asha C., Daneman, Nick, van Hal, Sebastiaan J., Heriot, George S., Lewis, Roger J., Lye, David C., Mcquilten, Zoe, Paterson, David L., Owen Robinson, J., Roberts, Jason A. ... Goodman, Anna L. (2023). Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol. Clinical Infectious Diseases, 79 (4), 871-887. doi: 10.1093/cid/ciad666 |
|
2023 Journal Article Avoiding misclassification of acute kidney injury: timing is everythingLegg, Amy, Roberts, Jason A., Roberts, Matthew A., Cass, Alan, Davies, Jane, Tong, Steven Y. C. and Davis, Joshua S. (2023). Avoiding misclassification of acute kidney injury: timing is everything. Nephrology, 29 (2), 100-104. doi: 10.1111/nep.14246 |
|
2023 Journal Article Optimal drug therapy for Staphylococcus aureus bacteraemia in adultsLegg, Amy, Davis, Joshua S. and Roberts, Jason A. (2023). Optimal drug therapy for Staphylococcus aureus bacteraemia in adults. Current Opinion in Critical Care, 29 (5), 446-456. doi: 10.1097/mcc.0000000000001072 |
|
2023 Journal Article Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysisLegg, Amy, Roberts, Matthew A., Davies, Jane, Cass, Alan, Meagher, Niamh, Sud, Archana, Daitch, Vered, Dishon-Benattar, Yael, Yahav, Dafna, Paul, Mical, Xinxin, Chen, He Ping, Yeo, Lye, David, Lee, Russel, Robinson, J Owen, Foo, Hong, Tramontana, Adrian R., Bak, Narin, Grenfell, Adelaide, Rogers, Benjamin, Li, Ying, Joshi, Neela, O’Sullivan, Matthew, McKew, Genevieve, Ghosh, Niladri, Schneider, Kellie, Holmes, Natasha E., Dotel, Ravindra, Chia, Timothy ... Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Study Group (2023). Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis. Open Forum Infectious Diseases, 10 (7) ofad337, 1. doi: 10.1093/ofid/ofad337 |
|
2023 Journal Article Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicityLegg, Amy, Carmichael, Sinead, Chai, Ming G., Roberts, Jason A. and Cotta, Menino O. (2023). Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicity. Antibiotics, 12 (5) 870, 1-14. doi: 10.3390/antibiotics12050870 |
|
2023 Journal Article Correction to: The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe (vol 75, pg 2027, 2022)Anagnostou, Nick, Archuleta, Sophia, Athan, Eugene, Barina, Lauren, Best, Emma, Bloomfield, Max, Bostock, Jennifer, Botheras, Carly, Bowen, Asha, Britton, Philip, Burden, Hannah, Campbell, Anita, Carter, Hannah, Cheng, Matthew, Chew, Ka Lip, Chong, Ivor Russel Lee Ming, Coombs, Geoffrey, Daley, Peter, Daneman, Nick, Davies, Jane, Davis, Joshua, Dishon-Benattar, Yael, Dotel, Ravindra, Dunlop, Adrian, Flack, Felicity, Flanagan, Katie, Foo, Hong, Ghanem-Zoubi, Nesrin, Giulieri, Stefano ... Yahav, Dafna (2023). Correction to: The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe (vol 75, pg 2027, 2022). Clinical Infectious Diseases, 76 (8), 1532-1533. doi: 10.1093/cid/ciac730 |
|
2023 Journal Article Sotrovimab use in young pediatric patients at high-risk of progression to severe COVID-19 diseaseWhite, Elizabeth, Legg, Amy, Bogart, Alexandra, Graham, Nicolette, Jebreen, Faten and Clark, Julia E. (2023). Sotrovimab use in young pediatric patients at high-risk of progression to severe COVID-19 disease. Journal of the Pediatric Infectious Diseases Society, 12 (4), 242-245. doi: 10.1093/jpids/piad020 |
|
2022 Journal Article Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 TrialLegg, Amy, Meagher, Niamh, Johnson, Sandra A., Roberts, Matthew A., Cass, Alan, Scheetz, Marc H., Davies, Jane, Roberts, Jason A., Davis, Joshua S. and Tong, Steven Y. C. (2022). Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial. Clinical Drug Investigation, 43 (1), 35-35. doi: 10.1007/s40261-022-01224-9 |
|
2022 Journal Article Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: a post hoc analysis of the CAMERA2 trialLegg, Amy, Meagher, Niamh, Johnson, Sandra A., Roberts, Matthew A., Cass, Alan, Scheetz, Marc H., Davies, Jane, Roberts, Jason A., Davis, Joshua S. and Tong, Steven Y. C. (2022). Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: a post hoc analysis of the CAMERA2 trial. Clinical Drug Investigation, 43 (1), 23-33. doi: 10.1007/s40261-022-01204-z |
|
2022 Journal Article Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)James, Fiona, Goh, Michelle S. Y., Mouhtouris, Effie, Vogrin, Sara, Chua, Kyra Y. L., Holmes, Natasha E., Awad, Andrew, Copaescu, Ana-Maria, De Luca, Joseph F., Zubrinich, Celia, Gin, Douglas, Cleland, Heather, Douglas, Abby, Kern, Johannes S., Katelaris, Constance H., Thien, Francis, Barnes, Sara, Yun, James, Tong, Winnie, Smith, William B., Carr, Andrew, Anderson, Tara, Legg, Amy, Bourke, Jack, MacKay, Laura K., Aung, Ar Kar, Phillips, Elizabeth J. and Trubiano, Jason (2022). Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR). BMJ Open, 12 (8) e055906, 1-7. doi: 10.1136/bmjopen-2021-055906 |
|
2022 Journal Article Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum?Coombes, Ian D., Legg, Amy, Patterson, Tina, Kelly, Tanya, Henderson, Andrew and Roberts, Jason A. (2022). Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum?. Australian Prescriber, 45 (2), 67-68. doi: 10.18773/austprescr.2022.021 |
|
2021 Journal Article The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trialMcCarthy, K. L., Harris-Brown, T., Smits, E. J., Legg, A., Chatfield, M. D. and Paterson, D. L. (2021). The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial. European Journal of Clinical Microbiology & Infectious Diseases, 40 (12), 2505-2513. doi: 10.1007/s10096-021-04294-3 |
